Literature DB >> 3478331

Decreased erythrocyte penetration of pefloxacin in cirrhotic patients.

C Silvain, J P Breux, E Rochard, S Bouquet, B Becq-Giraudon, M Beauchant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3478331     DOI： 10.1093/jac/20.2.290

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.

Authors:  C Silvain; S Bouquet; J P Breux; B Becq-Giraudon; M Beauchant
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.

Authors:  J Cardey; C Silvain; S Bouquet; J P Breux; B Becq-Giraudon; J P Fourtillan; M Beauchant
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 4.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.